Tag Archives: Imfinzi

Imfinzi (durvalumab) Approved in the US for Extensive-Stage Small Cell Lung Cancer

Print this page 30 March 2020 — AstraZeneca’s Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide). The approval by the Food and Drug Administration was based on positive results from… Read More »

AstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer

AstraZeneca is still stinging from Imfinzi’s combo flop in non-small cell lung cancer, but it’s already staring down another defeat. On Friday, the British drugmaker said the immuno-oncology drug had failed to show it could extend the lives of patients with recurrent or metastatic head and neck cancer whose disease has worsened after chemo. The… Read More »